Allele-specific restriction analysis of human platelet antigen system 4

Transfusion

Volumn 36, Issue 9, 1996, Pages 809-812

  Matsuo, K ^a   Reid, D M ^a,b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE ANTIGEN;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; DNA DETERMINATION; GENE AMPLIFICATION; GENOTYPE; HUMAN; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; THROMBOCYTOPENIA; THROMBOCYTOPENIC PURPURA;

EID: 0029797011     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36996420759.x     Document Type: Article

References (35)

1. 33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989;83:1778-81.
2. 145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 1992;89:381-4.
3. Murata M, Furihata K, Ishida F, et al. Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ibα involved in platelet transfusion refractoriness. Blood 1992;79:3086-90.
4. Kalb R, Santoso S, Unkelbach K, et al. Localization of the Br polymorphism on a 144 bpexon of the GPIα gene and its application in platelet DNA typing. Thromb Haemost 1994;71:651-4.
5. Kuijpers RW, Simsek S, Faber NM, et al. Single point mutation in human glycoprotein HIa is associated with a new platelet-specific alloantigen (Mo) involved in neonatal alloimmune thrombocytopenia. Blood 1993;81:70-6.
6. Wang R, McFarland JG, Kekomaki R, Newman PJ. Amino acid 489 is encoded by a mutational "hot spot" on the β3 integrin chain: the CA/TU human platelet alloantigen system. Blood 1993;82:3386-91.
7. Simsek S, Faber NM, Bleeker PM, et al. Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA (allele-specific restriction enzyme) analysis. Blood 1993;81:835-40.
8. A), Ko, Bak and Br (HPA-1, 2, 3, 5). Br J Haematol 1995;89:169-76.
9. Williamson LM, Bruce D, Lubenko A, et al. Molecular biology for platelet alloantigen typing. Transfus Med 1992;2:255-64.
10. Metcalfe P, Waters AH. HPA-1 typing by PCR amplification with sequence-specific primers (PCR-SSP): a rapid and simple technique. Br J Haematol 1993;85:227-9.
11. Skogen B, Bellissimo DB, Hessner MJ, et al. Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers. Transfusion 1994;34:955-60.
12. Tanaka S, Taniue A, Nagao N, et al. Simultaneous DNA typing of human platelet antigens 2, 3 and 4 by an allele-specific PCR method. Vox Sang 1995;68:225-30.
13. McFarland JG, Aster RH, Bussel JB, et al. Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele-specific oligonucleotide probes. Blood 1991;78:2276-82.
14. b alloantigen system. Blood 1990;75:2343-8.
15. a alloantigen system of GPIIIa. J Biol Chem 1994;269:8439-44.
16. Bray PF, Jin Y, Kickler T. Rapid genotyping of the five major platelet alloantigens by reverse dot-blot hybridization. Blood 1994;84:4361-7.
17. Friedman JM, Aster RH. Neonatal alloimmune thrombocytopenic purpura and congenital porencephaly in two siblings associated with a "new" maternal antiplatelet antibody. Blood 1985;65:1412-5.
18. a, a new platelet antigen involved in two cases of neonatal alloimmune thrombocytopenia. Vox Sang 1986;50:177-80.
19. b. Vox Sang 1986;51:334-6.
20. b is located on platelet membrane glycoprotein IIIa. Proc Jpn Acad 1987;63B:36-8.
21. a, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. J Clin Invest 1987;80:1624-30.
22. b alloantigen system. Proc Jpn Acad 1991;67B:102-6.
23. b alloantigen system. J Clin Invest 1992;90:2038-43.
24. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91.
25. Fitzgerald LA, Steiner B, Rall SC Jr, et al. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to "integrin." J Biol Chem 1987;262:3936-9.
26. a. Am J Hematol 1988;29:38-40.
27. a) neonatal alloimmune thrombocytopenia: first report in a Caucasian family. Transfus Med 1992;2:273-6.
28. Jin A, Zhang Y, Xia Y, et al. New restriction endonuclease CviRI cleaves DNA at TG∧CA sequences. Nucleic Acids Res 1994;22:3928-9.
29. Haliassos A, Chomel JC, Tesson L, et al. Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 1989;17:3606.
30. Sorscher EJ, Huang Z. Diagnosis of genetic disease by primer-specified restriction map modification, with application to cystic fibrosis and retinitis pigmentosa. Lancet 1991;337:115-8.
31. Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503-16.
32. Okayama H, Curiel DT, Brantly ML, et al. Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification. J Lab Clin Med 1989;114:105-13.
33. Wu DY, Ugozzoli L, Pal BK, Wallace RB. Allele-specific enzymatic amplification of β-globin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acac Sci U S A 1989;86:2757-60.
34. Kwok S, Kellogg DE, McKinney N, et al. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type I model studies. Nucleic Acids Res 1990;18:999-1005.
35. χ174 DNA: the effect of single base pair mismatch. Nucleic Acids Res 1979;6:3543-57.